The Pro-inflammatory Role of High-mobility Group Box 1 Protein (HMGB-1) in Photoreceptors and Retinal Explants Exposed to Elevated Pressure
Overview
Affiliations
To determine the role of high-mobility group box 1 protein (HMGB-1) in cellular and tissue models of elevated pressure-induced neurodegeneration, regeneration, and inflammation. Mouse retinal photoreceptor-derived cells (661W) and retinal explants were incubated either under elevated pressure or in the presence of recombinant HMGB-1 (rHMGB-1) to investigate the mechanisms of response of photoreceptors. Immunohistochemistry, western blotting, and the quantitative real-time PCR were used to examine the expression levels of immunological factors (eg, HMGB-1, receptor for advanced glycation end products (RAGE)), Toll-like receptors 2 and 4 (TLR-2, TLR-4), apoptosis-related factors (eg, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated death promoter (Bad)) as well as cytokine expression (eg, tumor necrosis factor alpha (TNF-α), interleukin (IL)-4, IL-6, and vascular endothelial growth factor (VEGF)). The data revealed increased the expression of HMGB-1 and its receptors RAGE, TLR-2, and TLR-4, and TNF-α as well as pro-apoptotic factors (eg, Bad) as well as apoptosis in 661W cells exposed to elevated pressure. Co-cultivation of 661W cells with rHMGB-1 increased the expression levels of pro-apoptotic Bad and cleaved Caspase-3 resulting in apoptosis. Cytokine array studies revealed an increased release of TNF-α, IL-4, IL-6, and VEGF after incubation of 661W cells with rHMGB-1. Upregulation of HMGB-1, TLR-2, and RAGE as well as anti-apoptotic Bcl-2 expression levels was found in the retinal explants exposed to rHMGB-1 or elevated pressure. The results suggest that HMGB-1 promotes an inflammatory response and mediates apoptosis in the pathology of photoreceptors and retinal homeostasis. HMGB-1 may have a key role in ongoing damage of retinal cells under conditions of elevated intraocular pressure.
Crystallin β-b2 promotes retinal ganglion cell protection in experimental autoimmune uveoretinitis.
Bauer D, Bohm M, Wu X, Wang B, Jalilvand T, Busch M Front Cell Neurosci. 2024; 18:1379540.
PMID: 39318470 PMC: 11419989. DOI: 10.3389/fncel.2024.1379540.
Ephrin B1 Regulates Inflammatory Pathways in Retinal Müller Cells.
Liu L, Jiang Y, Al-Shabrawey M, Steinle J J Diabetes Clin Res. 2024; 6(1):1-7.
PMID: 38501146 PMC: 10947218. DOI: 10.33696/diabetes.6.056.
AIBP: A New Safeguard against Glaucomatous Neuroinflammation.
Choi S, Choi S, Bastola T, Park Y, Oh J, Kim K Cells. 2024; 13(2).
PMID: 38275823 PMC: 10814024. DOI: 10.3390/cells13020198.
Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system.
Zhao L, Hou C, Yan N Front Immunol. 2022; 13:1059947.
PMID: 36389729 PMC: 9647059. DOI: 10.3389/fimmu.2022.1059947.
The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review.
Ikram F, Arulsamy A, Retinasamy T, Shaikh M Curr Neuropharmacol. 2022; 20(11):2221-2245.
PMID: 35034598 PMC: 9886836. DOI: 10.2174/1570159X20666220114153308.